Device Trial Radar · NCT00959322
A Prospective Single Center Clinical Study for Capsulotomy Using the LenSx 550 Laser
Last checked: Nov 20, 2026Latest source record: Oct 14, 2009 (this record)Source: ClinicalTrials.govMethods & limitations
Sponsor
- Lead sponsor
- LenSx Lasers Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Aug 14, 2009
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 24 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The LenSx 550 laser system is a femtosecond laser intended for use in performing anterior capsulotomy during cataract surgery. The anterior capsulotomy creates a circular opening in the anterior surface of the capsular bag that contains the cataractous crystalline lens. The objective of this study is to evaluate the ability of the LenSx 550 laser to successfully perform anterior capsulotomy during cataract surgery.
Conditions
- Cataract
Interventions
LenSx 550 Laser SystemDevice
Femtosecond laser used to create capsulotomy incision.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Capsulotomy is completeTime frame: 1 day, 1 week, 1 month
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Semmelweis University
Budapest, Hungary
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.